Ethical considerations in genomic testing for hematologic disorders
- Authors
- ACMG Board of Directors
- Amendola
- Amendola
- American Medical Association Council on Ethical and Judicial Affairs
- Armstrong
- Baxter
- Beauchamp
- Beller
- Berkman
- Blanchette
- Bradbury
- Brownstein
- Burke
- Clayton
- Collins
- Committee on Genetics, and American College of Medical Genetics, and Genomics Social, Ethical, Legal Issues Committee Committee on Bioethics
- Davis
- Davis
- Deininger
- Dewey
- Domchek
- Druker
- Druker
- D’Andrea
- D’Andrea
- Evans
- Feurstein
- Gambacorti-Passerini
- Garofalo
- Gollust
- Gray
- Gray
- Gray
- Green
- Hall
- Hamanoue
- Hartge
- Hirschhorn
- Hoeyer
- Holm
- Jonathan M. Marron
- Kabene
- Kantarjian
- Kaphingst
- Kaufman
- Kirsch
- Laberge
- Lantos
- Levine
- Levy-Lahad
- Li
- Mandal
- Manrai
- Marron
- Martinaud
- McGovern
- McGraw
- McGuire
- Miller
- Natarajan
- Need
- Nielsen
- Petrucelli
- Presidential Commission for the Study of Bioethical Issues
- Prince
- Pyeritz
- Raymond
- Richards
- Ritter
- Robson
- Rosenberg
- Ross
- Safken
- Scherr
- Shah
- Smedley
- Spratt
- Steven Joffe
- Struewing
- The American Society of Human Genetics Social Issues Subcommittee on Familial Disclosure
- United States of America
- Wolf
- World Health Organization
- Xu
- Yang
- Publication date
- Publisher
- 'American Society of Hematology'
- Doi